Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not been well studied in underserved populations. We surveyed 1,123 BRCA testers from a genetic counseling program serving an academic cancer center (n=1,045) and a public county hospital (n=78) a median of 3.7 years after testing for mutations in BRCA1 and BRCA2 (breast cancer susceptibility genes). We compared genetic counseling outcomes, cancer screening rates, and self-reported general health. We found no differences in genetic counseling outcomes between hospitals. Breast cancer screening rates were similarly high at both hospitals, which are warranted in this high-risk population. Screening rates for ovarian, colon, and skin cancer were signif...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Professionals who specialize in breast imaging may be the first to initiate the conversation about g...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
Given the increasing availability of health-related direct-to-consumer genetic testing (DTC-GT) and ...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Up to 10% of all breast and ovarian cancers are attributable to mutations in cancer susceptibility g...
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Professionals who specialize in breast imaging may be the first to initiate the conversation about g...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
Given the increasing availability of health-related direct-to-consumer genetic testing (DTC-GT) and ...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Up to 10% of all breast and ovarian cancers are attributable to mutations in cancer susceptibility g...
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Professionals who specialize in breast imaging may be the first to initiate the conversation about g...